ATE493143T1 - Kolloidale insluinformulierung mit langzeitwirkung und deren herstellung - Google Patents

Kolloidale insluinformulierung mit langzeitwirkung und deren herstellung

Info

Publication number
ATE493143T1
ATE493143T1 AT05776451T AT05776451T ATE493143T1 AT E493143 T1 ATE493143 T1 AT E493143T1 AT 05776451 T AT05776451 T AT 05776451T AT 05776451 T AT05776451 T AT 05776451T AT E493143 T1 ATE493143 T1 AT E493143T1
Authority
AT
Austria
Prior art keywords
long
relates
formulation
injectable
acting insulin
Prior art date
Application number
AT05776451T
Other languages
English (en)
Inventor
Alain Constancis
Florence Nicolas
Remi Meyrueix
Olivier Soula
Original Assignee
Flamel Tech Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Flamel Tech Sa filed Critical Flamel Tech Sa
Application granted granted Critical
Publication of ATE493143T1 publication Critical patent/ATE493143T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/773—Nanoparticle, i.e. structure having three dimensions of 100 nm or less
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/906—Drug delivery
AT05776451T 2004-07-19 2005-06-09 Kolloidale insluinformulierung mit langzeitwirkung und deren herstellung ATE493143T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0451578A FR2873040B1 (fr) 2004-07-19 2004-07-19 Formulation colloidale d'insuline longue action et sa preparation
PCT/FR2005/050431 WO2006016078A1 (fr) 2004-07-19 2005-06-09 Formulation colloïdale d'insuline longue action et sa preparation

Publications (1)

Publication Number Publication Date
ATE493143T1 true ATE493143T1 (de) 2011-01-15

Family

ID=34946786

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05776451T ATE493143T1 (de) 2004-07-19 2005-06-09 Kolloidale insluinformulierung mit langzeitwirkung und deren herstellung

Country Status (9)

Country Link
US (1) US8017156B2 (de)
EP (1) EP1771199B9 (de)
JP (1) JP4961343B2 (de)
AT (1) ATE493143T1 (de)
CA (1) CA2572868A1 (de)
DE (1) DE602005025638D1 (de)
FR (1) FR2873040B1 (de)
TW (1) TW200603827A (de)
WO (1) WO2006016078A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2822834B1 (fr) 2001-04-02 2005-02-25 Flamel Tech Sa Suspension colloidale de nanoparticules a base de copolymeres amphiphile pour la vectorisation de principes actifs et leur mode de preparation
FR2843117B1 (fr) 2002-07-30 2004-10-15 Flamel Tech Sa Polyaminoacides fonctionnalises par au moins un groupement hydrophobe et leurs applications notamment therapeutiques
FR2860516B1 (fr) 2003-10-03 2006-01-13 Flamel Tech Sa Homopolyaminoacides telecheliques fonctionnalises par des groupements hydrophobes et leurs applications notamment therapeutiques
FR2862536B1 (fr) 2003-11-21 2007-11-23 Flamel Tech Sa Formulations pharmaceutiques pour la liberation prolongee de principe(s) actif(s), ainsi que leurs applications notamment therapeutiques
JP4878463B2 (ja) * 2005-09-13 2012-02-15 ホソカワミクロン株式会社 ペプチドホルモン封入ナノ粒子を含む医薬製剤及びその製造方法
FR2896164B1 (fr) * 2006-01-18 2008-07-04 Flamel Technologies Sa Formulation colloidale d'insuline longue action et sa preparation
WO2009025802A1 (en) * 2007-08-21 2009-02-26 The Regents Of The University Of California Copolymer-stabilized emulsions
CA2843586A1 (fr) 2011-08-10 2013-02-14 Adocia Solution injectable d'au moins une insuline basale
CN104114155B (zh) 2012-01-09 2019-02-15 阿道恰公司 Ph为7并且至少包含pi为5.8至8.5之基础胰岛素和经取代共聚(氨基酸)的可注射溶液
US20150314003A2 (en) 2012-08-09 2015-11-05 Adocia Injectable solution at ph 7 comprising at least one basal insulin the isoelectric point of which is between 5.8 and 8.5 and a hydrophobized anionic polymer

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3837825A1 (de) 1988-11-08 1990-05-10 Hoechst Ag Neue insulinderivate, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
DK72793D0 (da) * 1993-06-21 1993-06-21 Novo Nordisk As Nyt produkt
FR2732218B1 (fr) 1995-03-28 1997-08-01 Flamel Tech Sa Particules a base de polyaminoacide(s) et susceptibles d'etre utilisees comme vecteurs de principe(s) actif(s) et leurs procedes de preparation
FR2746035B1 (fr) * 1996-03-15 1998-06-12 Microparticules de gel composite susceptibles d'etre utilisees comme vecteur(s) de principe(s) actif(s), l'un de leurs procedes de preparation et leurs applications
FR2801226B1 (fr) * 1999-11-23 2002-01-25 Flamel Tech Sa Suspension colloidale de particules submicroniques de vectorisation de principes actifs et son mode de preparation
FR2814952B1 (fr) * 2000-10-06 2004-01-02 Flamel Tech Sa Suspension colloidale de particules submicromiques de vectorisation de principes actifs et leur mode de preparation
CN100350364C (zh) * 2001-12-21 2007-11-21 西门子公司 采集和显示运动的装置
FR2840614B1 (fr) * 2002-06-07 2004-08-27 Flamel Tech Sa Polyaminoacides fonctionnalises par de l'alpha-tocopherol et leurs applications notamment therapeutiques

Also Published As

Publication number Publication date
EP1771199B9 (de) 2011-05-04
FR2873040B1 (fr) 2007-11-30
TW200603827A (en) 2006-02-01
DE602005025638D1 (de) 2011-02-10
FR2873040A1 (fr) 2006-01-20
EP1771199B1 (de) 2010-12-29
US8017156B2 (en) 2011-09-13
EP1771199A1 (de) 2007-04-11
US20090110742A1 (en) 2009-04-30
JP4961343B2 (ja) 2012-06-27
WO2006016078A1 (fr) 2006-02-16
JP2008506757A (ja) 2008-03-06
CA2572868A1 (fr) 2006-02-16

Similar Documents

Publication Publication Date Title
ATE493143T1 (de) Kolloidale insluinformulierung mit langzeitwirkung und deren herstellung
ECSP066477A (es) Composición farmacéutica que comprende ácido (2r)-2-propiloctanoico como un ingrediente activo
CU20080114A7 (es) Emulsión intravenosa de butilftalida y aplicación de la misma
CA2373266A1 (en) Use of exendins and agonists thereof for the treatment of gestational diabetes mellitus
CY1111874T1 (el) Ενεσιμη χορηγηση αριπιπραζολης
PE20061201A1 (es) Formulaciones liquidas estabilizadas de polipeptido
BRPI0917535A8 (pt) uso de insulina de ação ultra rápida
EP2676691A3 (de) Abgabe von viskosen Formulierungen durch nadellose Injektion
EA201170020A1 (ru) Пегилированные соединения инсулина лизпро
UY32765A (es) Preparaciones insulinicas de accion lenta
WO2006079641A3 (en) Insulin derivatives conjugated with structurally well defined branched polymers
MA34296B1 (fr) Composition retard injectable antipsychotique
AR078736A1 (es) Una solucion de droga de taxanos que comprende un regulador de ph y su metodo de preparacion
RU2015151135A (ru) Инъекционные гелевые нанокаркасы для лечения диабета
PH12015501931B1 (en) Treatment of diabetes mellitus by long-acting formulations of insulins
ATE542522T1 (de) Wässrige pharmazeutische formulierung
ATE539761T1 (de) Mittel für injektionszwecke mit einem antibiotikum und das mittel enthaltende lösung zur injektion
TW200616616A (en) Paclitaxel aqueous injection solution and methods for preparing the same
CL2008001332A1 (es) Uso de temozolomida para preparar un medicamento util para el tratamiento de un desorden proliferativo.
MX2021014332A (es) Formulaciones estabilizadas que contienen anticuerpos anti-angptl3.
WO2007076505A3 (en) Transferrin and transferrin-based compositions for diabetes treatment
EP4249069A3 (de) Wässrige lösung enthaltend 1-(4-{[4-(dimethylamino)-1-piperidinyl]carbonyl}phenyl)-3-{4-[4,6-di(4-morpholinyl)-1,3,5-triazin-2-yl]phenyl}harnstoff
TH76328A (th) สูตรผสมอินซูลินที่เป็นคอลลอยด์ที่ทำงานยาวนาน และการเตรียมสูตรผสม
US20210244858A1 (en) Soft tissue filler composition with hyaluronic acid and benzyl alcohol
AR049015A1 (es) Composicion farmaceutica que comprende acido (2r)-2-propiloctanoico como un ingrediente activo

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties